Glenmark Life Sciences IPO allotment: Check GMP and application status

]

New Delhi: Amidst a busy week in the primary market, investors are awaiting the debut of Glenmark Life Sciences after the stellar listing of Tatva Chintan Pharma Chem last week.However, the pharma player is losing its ground in the grey market. Last heard, it was commanding a premium of less than Rs 100 in the unofficial market, where the stock was trading at a premium of more than Rs 580 when the issue was announced.Analysts say that a poor sentiment in the pharma sector could be weighing on the company’s premium in the grey market.Investors are now awaiting for the listing of Glenmark Life Sciences. The basis of allotment is likely to be finalised by Tuesday, August 3. The shares of the company are expected to list on Friday, August 6.The Rs 1,514 crore issue, which was sold in the Rs 695-Rs 720 price band, received a strong investor response as it was subscribed over 44 times.The quota reserved for qualified institutional buyers (QIBs) was subscribed 37 times while the one reserved for non-institutional investors (NIIs) by 126 times. The retail quota was subscribed 15 times. Glenmark Life Sciences IPO received more than 39 lakh applications, the second-highest ever after Reliance Power IPO in 2008. The Rs 9,375 crore IPO of Zomato had received more than 32 lakh applications last month.Considering the FY-21 adjusted EPS of Rs 28.69 on a post-issue basis, the upper price band implies a P/E of 25.09 with a market cap of Rs 8,822 crore, while most of its peers are trading at higher valuations. The company, which is a spinoff of Glenmark Pharma, is in the Active Pharmaceutical Ingredient (API) business, analysts said.Investors, who had bid for the issue, can check the allotment status on the Bombay Stock Exchange (BSE) website:1) Visit https://www.bseindia.com/investors/appli_check.aspx2) Under the issue type, click Equity3) Under the issue name, select Glenmark Life Science Limited in the dropbox4) Write the application number5) Add the PAN card ID6) Click on ‘I am not a Robot’ and hit submit.You can also check the allotment status on the online portal of KFin Technologies Private Limited (https://https://evault.kfintech.com/ipostatus), the registrar to the issue.The registrar is a Sebi-registered entity, qualified to act as such and which electronically processes all applications, and carries out the allotment process as per the prospectus.The registrar is responsible for complying with the timelines for updating the electronic credit of shares to successful applicants, dispatch, and uploading of refunds, and attending to all investor-related queries after the issue is completed.1) Go to the web portal of KFin Technologies Private Limited2) Select the IPO in dropbox where the name will be populated only after the allotment is finalised3) You may be required to select either one of the three modes: Application number, Client ID or PAN ID4) In application type, select between ASBA and non-ASBA5) Enter the details of the mode you selected in Step 26) For security purposes, fill the captcha accurately7) Hit submit.Bidders who could not get allotment in the IPO may see the initialisation of refunds on Wednesday. Shares would be credited into the demat accounts of successful bidders by Thursday.

Glenmark Life Sciences IPO: How to check share allotment status online

]

Glenmark Life Sciences IPO: After getting subscribed for more than 44 times of its initial public offer, all eyes are now set on the share allotment date of ₹1,513.60 crore worth public issue. Glenmark Life Sciences IPO allotment date is 3rd August 2021 i.e. tomorrow and hence those who have applied for the IPO of the Active Pharmaceutical Ingredients (APIs) manufacturer company, are anxiously waiting for finalisation of the share allotment. For information to such bidders, they can check their application status online by logging in at the official BSE website or at the website of official registrar of this public issue — KFintech Private Limited.

How to check Glenmark Life Sciences IPO allotment status

As mentioned above, the Glenmark Life Sciences IPO bidders can check the allotment status online by logging in at the BSE website or at the official registrar KFintech’s website. The direct link to BSE website is bseindia.com/investors/appli_check.aspx. Bidders can check in at ris.kfintech.com/ipostatus/ipos.aspx, if they want to check their share allotment status by logging in at the official registrar’s website.

Glenmark Life Sciences IPO allotment status check at BSE

To check one’s share allotment status online at BSE, bidders can login at bseindia.com/investors/appli_check.aspx. After logging in, they need to follow some simple steps to check their application status online.

Here is step by step guide:

1] Login at direct BSE link — bseindia.com/investors/appli_check.aspx;

2] Enter ‘Glenmark Life Sciences IPO’ at the space given for issue name;

3] Enter your application number;

4] Enter your PAN details;

5] Click at ‘I’m not a robot’; and

6] Click at ‘Submit’ button.

Your Glenmark Life Sciences IPO application status will become available on the computer monitor or on the Smartphone screen.

Glenmark Life Sciences IPO allotment status check at KFintech

Those who want to check their application status online by logging in at the official registrar KFintech’s website, they are advised to login at the direct KFintech link — ris.kfintech.com/ipostatus/ipos.aspx. The website may not open due to sudden rise in traffic on the website. In such a scenario, bidders are advised to login again after some time.

Here is step by step guide:

1] Login at the direct KFintech link — ris.kfintech.com/ipostatus/ipos.aspx;

2] Click at either of the given links — 1, 2, 3 or 4;

3] Select Glenmark Life Sciences IPO at the space given for IPO name;

4] Choose the application type;

5] Enter your IPO application number;

6] Enter security code or Captcha; and

7] Click at ‘Submit’ button.

Your Glenmark Life Sciences share allotment status will become available on the computer monitor or on the Smartphone screen.

Subscribe to Mint Newsletters * Enter a valid email * Thank you for subscribing to our newsletter.

Glenmark Life Sciences IPO GMP falling, Why?

]

Follow us on Image Source : GLENMARKLIFESCIENCES.COM Glenmark Life Sciences IPO GMP falling, Why?

Glenmark Life Sciences IPO GMP is falling. Glenmark Life Sciences share price in the grey market is trading below a premium of Rs 100 apiece which is roughly around 15 per cent.

The fall in Glenmark Life Sciences GMP is because of the poor earnings of pharma companies. The sector’s result sent Nifty Pharma index to a level last seen in May 2021. The continued sell-off in the pharma sector pushed the pharma index below the 14,000 level.

This is the main reason why Glenmark Life Sciences IPO GMP is falling consistently. However, the current pharma stocks sell-off is said to be a short-term correction.

Glenmark Life Sciences is a subsidiary of Glenmark Pharmaceuticals. It is a leading developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences GMP Today

Glenmark Life Sciences IPO worth Rs 1,513.6 crore received bids for 66,33,24,160 shares against 1,50,18,279 shares on offer. Qualified Institutional Buyers(QIBs) portion received 36.97 times subscription and non-institutional investors a whopping 122.54 times. In the retail category, Glenmark Life Sciences IPO was subscribed 14.63 times.

The initial public offer comprised a fresh issue of up to Rs 1,060 crore and an offer for sale of up to 63 lakh equity shares. Its price range was at Rs Rs 695-720 per share. Glenmark Life Sciences earlier raised Rs 454 crore from anchor investors.

Glenmark Life Sciences shares were quoting at a premium of Rs 100. The shares were trading at Rs 820 apiece, a 14 per cent premium over IPO price.

Glenmark Life Sciences IPO Allotment

Glenmark Life Sciences will finalise the allotment of IPO on August 3 (Tuesday). Glenmark Life Sciences shares will be listed on the BSE and NSE on August 6 (Friday).

Glenmark Life Sciences said that the proceeds from the fresh issue will be used towards the payment of outstanding purchase consideration to the promoter for the spin-off of the API business and funding the capital expenditure requirements.

Latest Business News